Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Leukemia 2Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Megakaryoblastic, Acute 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Cell Culture Techniques × Clear all
NCT06041464 2023-09-18

Study of HLA-DR in Cell Cultures Isolated From Primary Squamous Cell Carcinoma

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Unknown
4 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡